Metabolic Remodeling and Mitochondrial Stress in Atrial Fibrillation: Mechanisms and Translational Targets
Open Access
- 18 December 2025
- journal article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (12)
Abstract
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and frequently co-occurs with metabolic diseases, such as diabetes and obesity. Due to the intricate and multifactorial pathophysiology of AF, this disorder often eludes effective prevention and durable control with current therapeutic strategies; thus, these strategies may not consistently mitigate the onset, persistence, and related adverse outcomes of AF. Moreover, atrial metabolic remodeling and mitochondrial stress can promote the development of atrial cardiomyopathy and AF through electrophysiological and structural changes. Hence, targeting these metabolic alterations may prevent the onset of this arrhythmia. A contemporary therapeutic paradigm prioritizes restoration of metabolic homeostasis, led by sodium–glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists and complemented by emerging mitochondria-targeted strategies with potential for incremental disease modification. Concurrently, integrative multi-omics is mapping atrial metabolic diversity in AF to support biomarker-guided, individualized interventions, while next-generation imaging is enhancing the detection of pathologic substrates and refining risk assessment. This review provides a comprehensive analysis of the mechanisms through which metabolic remodeling and mitochondrial stress cause AF, evaluates current experimental and diagnostic methods, and discusses emerging substrate-targeted therapies.Keywords
This publication has 217 references indexed in Scilit:
- Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviewsHeart Failure Reviews, 2023
- Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implicationsHerzschrittmachertherapie + Elektrophysiologie, 2023
- Cellular and mitochondrial mechanisms of atrial fibrillationBasic Research in Cardiology, 2020
- Pro‐inflammatory role of cell‐free mitochondrial DNA in cardiovascular diseasesIUBMB Life, 2020
- Functional significance of post-myocardial infarction inflammation evaluated by 18F-fluorodeoxyglucose imaging in swine modelJournal of Nuclear Cardiology, 2019
- Isolation of Mitochondria-Associated Membranes (MAM) from Mouse Brain Tissue2017
- Arrhythmia causes lipid accumulation and reduced glucose uptakeBasic Research in Cardiology, 2015
- Influence of DNA Structure on the Reactivity of the Guanine Radical CationChemistry – A European Journal, 2004
- Molecular Basis of Electrical Remodeling in Atrial FibrillationJournal of Molecular and Cellular Cardiology, 2000
- Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PETAnnals of Nuclear Medicine, 1999